Jackie Miller Provides an Overview of Virtua's Camp Oasis

Commentary
Article

Jackie Miller, RN, BSN, OCN, nurse navigator, Virtua Fox Chase Cancer Program, provides an overview of a day of fun, support and education for children and teens who have a loved one with cancer.

Jackie Miller, RN, BSN, OCN, nurse navigator, Virtua Fox Chase Cancer Program, provides an overview of a day of fun, support and education for children and teens who have a loved one with cancer.

Learn more about the program here.

Related Videos
Colleen O’Leary, DNP, RN, AOCNS, EBP-C, LSSYB, in an interview with Oncology Nursing News.
Michelle H. Johann, DNP, RN, PHN, CPAN, WTA, in an interview with Oncology Nursing News explaining surgical path cards
Alison Tray, of Hartford Healthcare, discusses her team's research on a multidisciplinary team approach to manage the cancer drug shortage
Related Content
We Advance, Together

We Advance, Together

February 29th 2024
Article
Fox Chase Cancer Center Nurse Navigators Improve Patient Services While Also Increasing Patient and Nurse Satisfaction

Fox Chase Cancer Center Nurse Navigators Improve Patient Services While Also Increasing Patient and Nurse Satisfaction

July 30th 2023
Article
lung cancer

Innovative Patient Education Strategies Continue to be Developed for Lung Cancer Screening

June 12th 2023
Article

Novel strategies for patient education can help to build trust in and decrease the fear of lung cancer screening among patients.

Patients With uHCC Who Experience irAEs With Tremelimumab/Durvalumab Achieve Numerical Improvements in OS

Patients With uHCC Who Experience irAEs With Tremelimumab/Durvalumab Achieve Numerical Improvements in OS

June 3rd 2023
Article

Tremelimumab plus durvalumab (STRIDE) showed a manageable immune-related adverse event profile in the phase 3 HIMALAYA trial.

Fox Chase Cancer Center Clinical Director Wins Oncology Nursing Society’s Excellence in Cancer Nursing Management Award

Fox Chase Cancer Center Clinical Director Wins Oncology Nursing Society’s Excellence in Cancer Nursing Management Award

April 14th 2023
Article
Exploratory Analysis Shows Histologic Subtype May Be Predictive of Immunotherapy Survival Benefit in Patients with Metastatic Nonsquamous NSCLC

Exploratory Analysis Shows Histologic Subtype May Be Predictive of Immunotherapy Survival Benefit in Patients with Metastatic Nonsquamous NSCLC

April 5th 2023
Article

Nivolumab/ipilimumab may offer superior overall survival to those with non–small cell lung cancer and solid tumor histology vs acinar histology.

© 2024 MJH Life Sciences

All rights reserved.